Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

116.93 +1.00 (+0.86%)
Streaming Delayed Price Updated: 1:36 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,123,419
Open 115.68
Bid (Size) 116.92 (1)
Ask (Size) 116.94 (2)
Prev. Close 115.93
Today's Range 115.14 - 117.15
52wk Range 99.71 - 121.64
Shares Outstanding 1,750,942,289
Dividend Yield 1.74%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What To Do After The Worst Week For Healthcare Stocks Since March 2020?
The market was quiet today but we should still expect some gains through year -end albeit a bit choppy. 
Via Talk Markets
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
Via Benzinga

Performance

YTD
+6.45%
+6.45%
1 Month
-0.05%
-0.05%
3 Month
+4.97%
+4.97%
6 Month
+11.55%
+11.55%
1 Year
+14.74%
+14.74%

More News

Read More
3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years
Via The Motley Fool
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
Via Investor's Business Daily
2 Dividend Kings That Would Have Doubled Your Money in 5 Years
Via The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
Via The Motley Fool
Analyst Ratings For Abbott Laboratories
Via Benzinga
Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial
Via Investor's Business Daily
P/E Ratio Insights for Abbott Laboratories
Via Benzinga
What You Missed On Wall Street This Past Friday
Via Talk Markets
AbbVie’s Dividend Isn’t As Scary As It Looks
Via Talk Markets
These Are The Top Health Stocks to Own for Buy-and-Hold Investing
Via MarketBeat
Exposures COVID-19
3 Dividend Growth Stocks You Can Buy and Hold Forever
Via The Motley Fool
Is Abbott Laboratories Stock a Buy?
Via The Motley Fool
Beat the Nasdaq With This Cash-Gushing Dividend Stock
Via The Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
Via The Motley Fool
MarketBeat Week in Review – 10/14 - 10/18
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
Via The Motley Fool
Abbott Labs Path to Double-Digit Earnings Growth In 2025? This Analyst Is Optimistic
Via Benzinga
These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings
Via Benzinga
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
Via Benzinga
Meta To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Why Abbott Laboratories Stock Was a Winner on Wednesday
Via The Motley Fool
Abbott Laboratories (ABT) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.